MRK
Price
$110.18
Change
-$1.90 (-1.70%)
Updated
Oct 3 closing price
27 days until earnings call
SNY
Price
$55.54
Change
-$0.71 (-1.26%)
Updated
Oct 3 closing price
21 days until earnings call
Ad is loading...

MRK vs SNY

Header iconMRK vs SNY Comparison
Open Charts MRK vs SNYBanner chart's image
Merck & Co
Price$110.18
Change-$1.90 (-1.70%)
Volume$10.28M
CapitalizationN/A
Sanofi ADS
Price$55.54
Change-$0.71 (-1.26%)
Volume$1.76M
CapitalizationN/A
View a ticker or compare two or three
MRK vs SNY Comparison Chart
Loading...
MRK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SNY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
MRK vs. SNY commentary
Oct 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRK is a Buy and SNY is a Buy.

COMPARISON
Comparison
Oct 04, 2024
Stock price -- (MRK: $110.18 vs. SNY: $55.54)
Brand notoriety: MRK: Notable vs. SNY: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: MRK: 102% vs. SNY: 108%
Market capitalization -- MRK: $331.75B vs. SNY: $122.61B
MRK [@Pharmaceuticals: Major] is valued at $331.75B. SNY’s [@Pharmaceuticals: Major] market capitalization is $122.61B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MRK’s FA Score shows that 3 FA rating(s) are green whileSNY’s FA Score has 3 green FA rating(s).

  • MRK’s FA Score: 3 green, 2 red.
  • SNY’s FA Score: 3 green, 2 red.
According to our system of comparison, SNY is a better buy in the long-term than MRK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MRK’s TA Score shows that 3 TA indicator(s) are bullish while SNY’s TA Score has 4 bullish TA indicator(s).

  • MRK’s TA Score: 3 bullish, 4 bearish.
  • SNY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SNY is a better buy in the short-term than MRK.

Price Growth

MRK (@Pharmaceuticals: Major) experienced а -2.57% price change this week, while SNY (@Pharmaceuticals: Major) price change was -2.56% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.09%. For the same industry, the average monthly price growth was -3.25%, and the average quarterly price growth was +6.39%.

Reported Earning Dates

MRK is expected to report earnings on Oct 31, 2024.

SNY is expected to report earnings on Oct 25, 2024.

Industries' Descriptions

@Pharmaceuticals: Major (-1.09% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRK($332B) has a higher market cap than SNY($123B). MRK has higher P/E ratio than SNY: MRK (935.64) vs SNY (20.80). SNY YTD gains are higher at: 16.417 vs. MRK (4.774). SNY has higher annual earnings (EBITDA): 12.6B vs. MRK (6.91B). SNY has more cash in the bank: 8.98B vs. MRK (7.09B). SNY has less debt than MRK: SNY (18.4B) vs MRK (35.1B). MRK has higher revenues than SNY: MRK (60.1B) vs SNY (46.4B).
MRKSNYMRK / SNY
Capitalization332B123B270%
EBITDA6.91B12.6B55%
Gain YTD4.77416.41729%
P/E Ratio935.6420.804,498%
Revenue60.1B46.4B130%
Total Cash7.09B8.98B79%
Total Debt35.1B18.4B191%
FUNDAMENTALS RATINGS
MRK vs SNY: Fundamental Ratings
MRK
SNY
OUTLOOK RATING
1..100
5769
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
11
Undervalued
PROFIT vs RISK RATING
1..100
1228
SMR RATING
1..100
2982
PRICE GROWTH RATING
1..100
5946
P/E GROWTH RATING
1..100
9812
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNY's Valuation (11) in the Pharmaceuticals Major industry is in the same range as MRK (15). This means that SNY’s stock grew similarly to MRK’s over the last 12 months.

MRK's Profit vs Risk Rating (12) in the Pharmaceuticals Major industry is in the same range as SNY (28). This means that MRK’s stock grew similarly to SNY’s over the last 12 months.

MRK's SMR Rating (29) in the Pharmaceuticals Major industry is somewhat better than the same rating for SNY (82). This means that MRK’s stock grew somewhat faster than SNY’s over the last 12 months.

SNY's Price Growth Rating (46) in the Pharmaceuticals Major industry is in the same range as MRK (59). This means that SNY’s stock grew similarly to MRK’s over the last 12 months.

SNY's P/E Growth Rating (12) in the Pharmaceuticals Major industry is significantly better than the same rating for MRK (98). This means that SNY’s stock grew significantly faster than MRK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MRKSNY
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
31%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
54%
Momentum
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
44%
MACD
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 2 days ago
46%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
46%
Bearish Trend 2 days ago
45%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
41%
Bearish Trend 2 days ago
38%
Advances
ODDS (%)
Bullish Trend 17 days ago
48%
Bullish Trend 4 days ago
54%
Declines
ODDS (%)
Bearish Trend 8 days ago
45%
Bearish Trend 2 days ago
44%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
57%
Aroon
ODDS (%)
Bullish Trend 2 days ago
49%
Bullish Trend 2 days ago
49%
View a ticker or compare two or three
Ad is loading...
MRK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SNY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERX41.101.89
+4.82%
Vertex
NXTC1.330.02
+1.53%
NextCure
CMCO35.320.20
+0.57%
Columbus McKinnon Corp
O62.42-0.58
-0.92%
Realty Income Corp
DSGN4.97-0.18
-3.50%
Design Therapeutics

MRK and

Correlation & Price change

A.I.dvisor tells us that MRK and AZN have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MRK and AZN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRK
1D Price
Change %
MRK100%
-2.32%
AZN - MRK
30%
Poorly correlated
+1.16%
GSK - MRK
23%
Poorly correlated
-2.11%
SNY - MRK
22%
Poorly correlated
-1.85%
JNJ - MRK
22%
Poorly correlated
-0.51%
NVS - MRK
21%
Poorly correlated
-0.07%
More

SNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNY has been loosely correlated with AZN. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if SNY jumps, then AZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNY
1D Price
Change %
SNY100%
-1.26%
AZN - SNY
37%
Loosely correlated
-2.07%
NVS - SNY
36%
Loosely correlated
-0.61%
JNJ - SNY
36%
Loosely correlated
-0.42%
GILD - SNY
32%
Poorly correlated
-0.67%
GSK - SNY
30%
Poorly correlated
-2.74%
More